Searchable abstracts of presentations at key conferences in endocrinology

ea0038p321 | Pituitary | SFEBES2015

Current clinical management of acromegaly in the UK; a survey of endocrinologists

Edwards Joanne , Siva Vathani , Baldock Laura , Ayuk John

Background: Acromegaly treatment options include transsphenoidal surgery (TSS), medical management with somatostatin analogues (SSAs), growth hormone (GH) receptor antagonists and dopamine agonists, radiotherapy or a combination of these, depending on symptom nature and severity, tumour size, age and health status. In 2014 the Endocrine Society published guidelines for management of acromegaly.Methods: To describe current UK practice following guideline ...

ea0037oc2.3 | Reproduction | ECE2015

Restoration of fertility in hypogonadal LH receptor null background male mice by a constitutive active mutant FSH receptor

Oduwole Olayiwola , Peltoketo Hellevi , Poliandri Ariel , Vengadabady Laura , Huhtaniemi Ilpo

The gonadotropic hormones, LH and FSH are critical regulators of normal sexual functions including steroidogenesis and gametogenesis. Their essential role is underscored by the development of various hypogonadal phenotypes arising from genetic mutations. Constitutive activation of their cognate receptors also disturbs their function. We earlier showed that transgenic expression of an activating mouse Fshr mutant (mFSHRD580H) in granulosa c...

ea0037ep34 | Adrenal cortex | ECE2015

Selective adrenal venous sampling is not always useful in primary aldosteronism

Paja Miguel , Pena Borja , Calles Laura A , Moreno Cristina

Adrenal venous sampling (AVS) is regarded as the gold-standard for the study of lateralisation of primary aldosteronism (PA) after its biochemical diagnosis. After catheterisation of both adrenal veins, confirmed by ratio of cortisol concentration in each adrenal vein and peripheral vein (selectivity index (SI)), lateralization is accepted if aldosterone/cortisol (A/C) ratio between both adrenal veins is over 3–4 (lateralization index (LI)), particularly if non-dominant v...

ea0037ep1244 | Clinical Cases–Pituitary/Adrenal | ECE2015

Slipped upper femoral epiphysis: a rare clinical manifestation of MEN2: a case report

Slattery Laura , Doherty Jayne , O'Shea Donal , McKenna Malachi , Crowley Rachel

Introduction: Multiple endocrine neoplasia type 2 (MEN2) comprise a group of heritable disorders that result from mutations in the RET proto-oncogene on chromosome 10. MEN2 is sub classified into MEN2A and MEN2B; these syndromes are characterised by the development of tumours at multiple sites. MEN2A is characterised by medullary thyroid cancer, phaeochromocytoma, and primary parathyroid hyperplasia.Description/case presentation: The index case is a 49 y...

ea0036P17 | (1) | BSPED2014

Neonatal seizure: a rare presentation of maternal hyperparathyroidism

Dunn Lucy , Ashmore Laura , Randell Tabitha , Denvir Louise , Sachdev Pooja

Introduction: Hypocalcaemia is a recognised cause of neonatal seizures most often related to vitamin D deficiency in the mothers of exclusively breast fed infants. There have also been case reports of an underlying diagnosis of hyperparathyroidism in a reportedly well mother becoming apparent after the infant presents with hypocalcaemic seizures. Maternal hypercalcaemia suppresses parathyroid activity in the foetus, which causes transient neonatal hypocalcaemia.<p class="a...

ea0036P75 | (1) | BSPED2014

Relationship between IGF1 concentration and growth velocity in infants and toddlers

Losa Laura , Beisti-Ortego Anunciacion , Dattani Mehul T

Background: IGF1 is the biochemical marker of growth as it is supposed to reflect the activity of the GH axis. The usefulness of IGF1 measurements in children under 3 years has not been verified to date.Aim: We analysed the relationship between serum IGF1 concentration and growth velocity (GV) in children under the age of 3 years.Methods: We compared 300 IGF1 concentrations taken in children younger than 3 years with their GV at ti...

ea0035p235 | Clinical case reports Pituitary/Adrenal | ECE2014

A history of 30 years severe uncontrolled hypertension: Conn's syndrome

Baleanu Felicia , Iconaru Laura , Bourmorck Carole , Karmali Rafik

A 65-year-old Moroccan man was regularly followed in the outpatient clinic for type 2 diabetes since 2010 and was well controlled with an oral treatment. His past medical history included severe hypertension since 1985. Despite four antihypertensive agents, his blood pressure was not controlled (BP: 220/120 mmHg). A suspicion of renal artery stenosis was excluded by an invasive procedure.He presented an impaired renal function (GFR: 50 ml/min) and his se...

ea0035p236 | Clinical case reports Pituitary/Adrenal | ECE2014

Unusual cause of hypoglycemia in a type 2 diabetic patient: panhypopituitarism

Baleanu Felicia , Iconaru Laura , Bourmorck Carole , Rafik Karmali

We report on a 50-year-old patient of Moroccan origin, with insulin treated type 2 diabetes known for several years. He presented with a 6 months history of hypoglycemia, hypotension, associated with loss of libido and erectile dysfunction, anorexia, general deterioration and weakness. He had lost 20 kg over a 6-month period. The insulin doses were diminished from 70 to 42 U/day and the antihypertensive treatment was stopped due to repeated episodes of hypotension.<p class...

ea0035p242 | Clinical case reports Pituitary/Adrenal | ECE2014

Congenital panhipopituitarism and ectopic posterior pituitary

Laura Iconaru , Felicia Baleanu , Carole Bourmorck , Rafik Karmali

Introduction: Congenital hypopituitarism may be the result of complications linked with delivery or may sometimes result of insufficient development of the gland in the context of specific genetic abnormalities (PROK2 and PROKR2, LHX4, HESX1, OTX2, GLI2 and SOX3). Interruption or lack of pituitary stalk represents a frequent feature of congenital hypopituitarism.Case description: We present a patient 39-year-old with congenital panhypopituitarism, mental...

ea0034p239 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2014

Upregulation of AKR1C3 expression by insulin in a human differentiated preadipocyte cell line

House Philip , O'Reilly Michael , Gathercole Laura , Tomlinson Jeremy

Polycystic ovary syndrome (PCOS) is a clinical triad of anovulation, hyperinsulinaemia, and androgen excess. Adipose androgen generation of testosterone from androstenedione by aldo-ketoreductase type 1C3 (AKR1C3) may contribute to hyperandrogenism. We hypothesised that insulin may upregulate adipose AKR1C3 expression in vitro in a human differentiated preadipocyte cell line.We analysed AKR1C3 expression in the SGBS human preadipocyte cell line....